These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21159862)

  • 1. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers.
    Williams LD; Bansal A; Sabbaj S; Heath SL; Song W; Tang J; Zajac AJ; Goepfert PA
    J Virol; 2011 Mar; 85(5):2316-24. PubMed ID: 21159862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function.
    Chevalier MF; Jülg B; Pyo A; Flanders M; Ranasinghe S; Soghoian DZ; Kwon DS; Rychert J; Lian J; Muller MI; Cutler S; McAndrew E; Jessen H; Pereyra F; Rosenberg ES; Altfeld M; Walker BD; Streeck H
    J Virol; 2011 Jan; 85(2):733-41. PubMed ID: 21047960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
    PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.
    Emu B; Sinclair E; Hatano H; Ferre A; Shacklett B; Martin JN; McCune JM; Deeks SG
    J Virol; 2008 Jun; 82(11):5398-407. PubMed ID: 18353945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.
    Walker-Sperling VE; Buckheit RW; Blankson JN
    J Virol; 2014 Sep; 88(17):9789-98. PubMed ID: 24942573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control.
    Yue FY; Lo C; Sakhdari A; Lee EY; Kovacs CM; Benko E; Liu J; Song H; Jones RB; Sheth P; Chege D; Kaul R; Ostrowski MA
    J Immunol; 2010 Jul; 185(1):498-506. PubMed ID: 20519650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
    Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
    Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.
    Rosás-Umbert M; Llano A; Bellido R; Olvera A; Ruiz-Riol M; Rocafort M; Fernández MA; Cobarsi P; Crespo M; Dorrell L; Del Romero J; Alcami J; Paredes R; Brander C; Mothe B
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Controllers Exhibit Effective CD8
    Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD
    Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells.
    Streeck H; Jolin JS; Qi Y; Yassine-Diab B; Johnson RC; Kwon DS; Addo MM; Brumme C; Routy JP; Little S; Jessen HK; Kelleher AD; Hecht FM; Sekaly RP; Rosenberg ES; Walker BD; Carrington M; Altfeld M
    J Virol; 2009 Aug; 83(15):7641-8. PubMed ID: 19458000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
    Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
    Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
    Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.
    Ferrando-Martínez S; Casazza JP; Leal M; Machmach K; Muñoz-Fernández MÁ; Viciana P; Koup RA; Ruiz-Mateos E
    J Virol; 2012 Apr; 86(7):3667-74. PubMed ID: 22278254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
    Mujib S; Jones RB; Lo C; Aidarus N; Clayton K; Sakhdari A; Benko E; Kovacs C; Ostrowski MA
    J Immunol; 2012 Apr; 188(8):3745-56. PubMed ID: 22422881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21 Expands HIV-1-Specific CD8
    Wu K; Zhang S; Zhang X; Li X; Hong Z; Yu F; Liu B; Pan T; Huang Z; Tang XP; Cai W; Xia J; Li X; Zhang H; Zhang Y; Li L
    J Immunol Res; 2019; 2019():1801560. PubMed ID: 31183385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
    Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
    Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.
    Ndhlovu ZM; Proudfoot J; Cesa K; Alvino DM; McMullen A; Vine S; Stampouloglou E; Piechocka-Trocha A; Walker BD; Pereyra F
    J Virol; 2012 Jun; 86(12):6959-69. PubMed ID: 22514340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.